Clinical Trials Browser

Phase 2/3 × INDUSTRY × Endometrial Neoplasms × Clear all

NCT06321068 2025-08-14

BAT1308 in Combination With Platinum-containing Chemotherapy is Used for the First-line Treatment of Advanced or Recurrent dMMR Endometrial Cancer

Phase 2/3 Terminated

Endometrial Neoplasms

NCT05797831 2024-05-02

Study of Navtemadlin as Maintenance Therapy in TP53WT Advanced or Recurrent Endometrial Cancer

Phase 2/3 Recruiting

Endometrial Neoplasms